Neuropsychiatric Disorders and Epigenetics

Neuropsychiatric Disorders and Epigenetics

3 (1 rating by Goodreads)
Edited by  , Edited by  , Edited by 

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?


Neuropsychiatric Disorders and Epigenetics is a comprehensive reference for the epigenetic basis of most common neuropsychiatric disorders. The volume is organized into chapters representing individual neuropsychiatric disorders, from addition to obesity contributed by leading experts in their respective fields. The epigenetic aspects of each disorder are discussed, in the context of the full range of epigenetic mechanisms including DNA modification, histone post-translational modification, chromatin organization and non-coding RNA. A particular emphasis is placed on potential epigenetic interventions, when the effects of environmental stimuli on epigenetic states is particularly relevant o disease.

Recent discoveries in epigenetic research enabled by epic advances in genomic technologies have positioned the field for broad translation to therapeutic interventions for previously unmanageable disorders Neuropsychiatric disorders represent a prime target of epigenetic interventions as they are highly debilitating, often chronic diseases with enormous costs to society. Thus, this volume will help define epigenetics as a key player in neuropsychiatric disorders, highlighting the full spectrum of epigenetic mechanisms underlying such disorders and introducing the vast range of epigenetic therapies under development.
show more

Product details

  • Hardback | 444 pages
  • 152 x 229 x 25.4mm | 1,070g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 80; Illustrations, unspecified
  • 0128002263
  • 9780128002261

Table of contents

Preface Dag H. Yasui, Jacob Peedicayil and Dennis R. Grayson

Section I. Neuropsychiatric Disorders and Epigenetics: General Aspects 1. Introduction to Neuropsychiatric Disorders and Epigenetics Dag H. Yasui, Jacob Peedicayil and Dennis R. Grayson

2. Environmental Factors and Epigenetics of Neuropsychiatric Disorders Anke Hoffmann and Dietmar Spengler

3. Epigenetic Biomarkers in Neuropsychiatric Disorders Chin-Chuen Lin, Tiao-Lai Huang

Section II: Epigenetics of Neuropsychiatric Disorders 4. Epigenetics and Cognitive Disorders -Translational Aspects Fabio Coppede

5. Epigenetics in Pervasive Developmental Disorders - Translational Aspects Takeo Kubota

6. Epigenetic causes of intellectual disability - the fragile X syndrome paradigm Elisabetta Tabolacci, Giovanni Neri

7. Epigenetics of Attention-Deficit Hyperactivity Disorder Nader Perroud, Sebastien Weibel, Jean-Michel Aubry, Alexandre Dayer

8. The epigenetics of brain aging and psychiatric disorders Huan Gong, Xiangru Xu

9. Epigenetic therapy may alleviate cognitive deficits in Down syndrome by downregulating overexpressed chromosome 21 gene products Alain D. Dekker, Peter P. De Deyn and Marianne G. Rots

10. Epigenetics and Multiple Sclerosis Lara Kular, Goncalo Castelo-Branco and Maja Jagodic

11. Epigenetics and Migraine Siew Hua Gan and Munvar Miya Shaik

12. The role of epigenetics in the pathophysiology of epilepsy Sung Min Nam and Kyung-Ok Cho

13. Epigenetic Dysregulation in Brain Tumors and Neurodevelopment Marco M. Hefti and Nadejda Tsankova

14. Epigenetics and Cerebrovascular Diseases Carolina Soriano-Tarraga, Jordi Jimenez-Conde and Jaume Roquer

15. Epigenetics and Eating Disorders Helge Frieling, Vanessa Buchholz

16. Epigenetics in Obesity Brian M. Shewchuk

17. Epigenetics and Drug Addiction-Translational Aspects Jian Feng

18. Epigenetics and Alcohol Use Disorders Sneha Sagarkar and Amul Sakharkar

Section III: Summary and Outlook 19. Summary and Outlook Dag H. Yasui, Jacob Peedicayil and Dennis R. Grayson
show more

About Dennis R. Grayson

Dag Yasui is senior project scientist at UC Davis' Department of Medical Microbiology and Immunology. His current research program is in the field of chromatin and gene expression regulation in autism spectrum disorders. Jacob Peedicayil has published 46 review papers, 3 book chapters and is engaged in various editorial review boards and journal positions. His interests include theoretical research in psychiatric epigenetics and muscle-based pharmacology. Dr. Grayson has been interested in mechanisms associated with gene expression for over 20 years. He joined the laboratory of Dr. James E. Darnell, Jr. at the Rockefeller University on 1984 to study cell-type specific transcription factors. This led to the identification of HNF3A as a hepatocyte nuclear factor important for activating the expression of multiple genes in hepatocytes. In 1988, Dr. Grayson joined the Fidia-Georgetown Institute for the Neurosciences and with the support of Dr. Erminio Costa, initiated a program in studying gene expression in neurons. From 1994-1998, he moved to the Allegheny University of the Health Sciences in Pittsburgh and developed a program in molecular psychiatry. He continued his interests in psychiatry and joined the Psychiatric Institute in 1998. This represented a unique opportunity to join his long time collaborators, Drs. Costa and Guidotti to pursue molecular underpinnings of schizophrenia. Dr. Grayson has received NRSA post-doctoral support, R01 and K04 funding from the NIH over the years. He has published over 100 papers in peer-reviewed journals and actively reviews NIH grants and post-doctoral fellowships. In addition, Dr. Grayson has been invited to speak at numerous national and international meetings.
show more

Rating details

1 ratings
3 out of 5 stars
5 0% (0)
4 0% (0)
3 100% (1)
2 0% (0)
1 0% (0)
Book ratings by Goodreads
Goodreads is the world's largest site for readers with over 50 million reviews. We're featuring millions of their reader ratings on our book pages to help you find your new favourite book. Close X